SCHEMBL15519527

SCHEMBL15519527

CC(CCc1noc(-c2ccc(F)c(F)c2)n1)NC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.41
S1PR3 Q99500 1/20 0.41
S1PR5 Q9H228 1/20 0.41
PPARG P37231 6/20 0.40
PPARA Q07869 6/20 0.40
PPARD Q03181 4/20 0.40
CSGALNACT1 Q8TDX6 1/20 0.39
MAPT P10636 3/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HSD17B10 Q99714 2/20 0.39
NPC1 O15118 1/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CHRNB2 P17787 1/20 0.38
CHRNA5 P30532 1/20 0.38
CHRNA4 P43681 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30567900 0.76 CHRNB2 (0.46) S1PR1S1PR3S1PR5MAPTNPC1
SCHEMBL25382664 0.76 CHRNB2 (0.46) S1PR1S1PR3S1PR5MAPTNPC1
SCHEMBL16781384 0.75 PPARG (0.51) PPARGPPARAPPARDNPC1RAB9A
SCHEMBL13833143 0.75 ALDH1A1 (0.48) MAPTALDH1A1KDM4EHSD17B10NPC1
SCHEMBL15519525 0.74 ALDH1A1 (0.45) S1PR1S1PR3S1PR5PPARGPPARA
SCHEMBL25381836 0.72 KCNH2 (0.44) S1PR1MAPTALDH1A1KDM4ERAB9A
SCHEMBL13833216 0.68 ALDH1A1 (0.39) PPARGPPARAPPARDMAPTALDH1A1
SCHEMBL15520392 0.67 HCRTR1 (0.54)
SCHEMBL13899403 0.66 NPC1 (0.51) PPARGPPARAPPARDMAPTALDH1A1
SCHEMBL16648663 0.65 HCRTR1 (0.51) S1PR1S1PR3S1PR5PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140081025-A1 HETEROAROMATIC RING DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-03-20 US disclosed
EP-2708537-A1 HETEROAROMATIC RING DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2014-03-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140081025-A1 HETEROAROMATIC RING DERIVATIVE HCRTR2, HCRTR1, HTT S1PR1 1481/4885S1PR3 2387/4885S1PR5 2288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.